ARQT · Arcutis Biotherapeutics, Inc. · Executive Compensation

$26.41 -0.02 (-0.08%)

S&P 600 member Russell 2000 member Rebalance outlook locked

Market Cap

$3.39B

125.69M

Volume · Sep 30 2.39M Avg daily vol (3M) 2.18M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Todd Franklin Watanabe	President and Chief Executive Officer	$713,333	—	$2,067,190	$3,848,958	$579,584	$14,000	$7,223,065
L. Todd Edwards	Chief Commercial Officer	$535,000	—	$752,950	$1,380,182	$334,376	$27,829	$3,030,337
Todd Edwards	—	$535,000	—	$752,950	$1,380,182	$334,376	$27,829	$3,030,337
Patrick Burnett	M.D., Ph.D. Chief Medical Officer	$535,000	—	$752,950	$1,380,182	$334,376	$14,000	$3,016,508
Masaru Matsuda	Chief Legal Officer	$495,167	—	$465,460	$865,044	$278,532	$14,000	$2,118,203
David Topper	Former Chief Financial Officer	$196,458	—	$465,460	$865,044	—	$419,771	$1,946,733
Latha Vairavan	Chief Financial Officer	$419,485	—	$440,413	$839,463	$213,402	$12,017	$1,924,780

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
David Topper	Chief Financial Officer	$364,792	—	$1,854,200	$2,772,155	$296,640	$23,416	$5,311,203
Todd Franklin Watanabe	President and Chief Executive Officer	$660,867	—	$1,405,630	$1,053,227	$549,841	$19,926	$3,689,491
Patrick Burnett	M.D., Ph.D. Chief Medical Officer	$504,203	—	$989,282	$709,002	$293,274	$17,289	$2,513,050
John Smither	Chief Financial Officer	$183,333	—	$1,053,771	$759,714	$105,600	—	$2,102,418
Todd Edwards	—	$516,419	—	$679,120	$452,117	$300,311	$17,178	$1,965,145
L. Todd Edwards	Chief Commercial Officer	$516,419	—	$679,120	$452,117	$300,311	$17,178	$1,965,145
Masaru Matsuda	—	$465,472	—	$535,475	$452,117	$268,112	$16,356	$1,737,532

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Todd Franklin Watanabe	President and Chief Executive Officer	$633,500	—	$1,384,250	$2,543,320	$354,127	$20,069	$4,935,266
Patrick Burnett	M.D., Ph.D. Chief Medical Officer	$477,267	—	$332,220	$611,185	$230,878	$14,795	$1,666,345
L. Todd Edwards	Chief Commercial Officer	$131,254	—	$334,800	$938,855	$241,883	$11,055	$1,657,847
Todd Edwards	—	$131,254	—	$334,800	$938,855	$241,883	$11,055	$1,657,847
Masaru Matsuda	Chief Legal Officer	$434,027	—	$332,220	$611,185	$209,961	$15,756	$1,603,149
General Counsel	—	$434,027	—	$332,220	$611,185	$209,961	$15,756	$1,603,149
John Smither	Chief Financial Officer	$200,886	—	—	$738,160	$97,179	—	$1,036,225

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
General Counsel	—	$415,000	—	$1,123,821	$3,392,725	$190,901	$20,317	$5,142,764
Masaru Matsuda	—	$415,000	—	$1,123,821	$3,392,725	$190,901	$20,317	$5,142,764
Todd Franklin Watanabe	President and Chief Executive Officer	$590,000	—	$1,252,803	$2,314,700	$407,100	$16,952	$4,581,555
Patrick Burnett	M.D., Ph.D. Chief Medical Officer	$457,167	—	$314,526	$579,598	$210,297	$22,490	$1,584,078
Kenneth Lock	—	$392,500	—	$235,011	$434,391	$180,550	$27,566	$1,270,018
Scott Burrows	Chief Financial Officer	$386,667	—	$235,011	$434,391	$177,867	$12,200	$1,246,136

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
John Smither	Chief Financial Officer	$100,000	—	$755,233	$5,384,317	—	$10,752	$6,250,292
Todd Franklin Watanabe	President and Chief Executive Officer	$525,000	—	$1,060,788	$2,283,138	$393,750	$21,447	$4,284,123
Matthew R. Moore	Chief Business Officer	$356,704	—	—	$3,234,036	$178,352	$25,012	$3,794,104
Scott Burrows	Chief Financial Officer	$330,750	—	$90,832	$1,481,820	$165,375	$11,600	$2,080,377
Patrick Burnett	M.D., Ph.D. Chief Medical Officer	$437,500	—	$308,180	$662,847	$218,750	$43,851	$1,671,128
Chief Commercial	Officer	$373,333	—	$308,180	$662,847	$186,667	$33,354	$1,564,381
David W. Osborne	Chief Technical Officer	$375,000	—	$308,180	$662,847	$187,500	$22,051	$1,555,578

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Patrick Burnett	M.D., Ph.D. Chief Medical Officer	$170,833	—	$867,315	$5,601,100	$209,100	$696	$6,849,038
Todd Franklin Watanabe	President and Chief Executive Officer	$441,667	—	$800,690	$1,215,563	$281,563	$11,400	$2,750,883
Kenneth Lock	—	$335,000	—	$248,490	$504,926	$170,850	$8,426	$1,267,692
Chief Commercial	Officer	$335,000	—	$248,490	$504,926	$170,850	$8,426	$1,267,692

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Todd Franklin Watanabe	President and Chief Executive Officer	$390,000	—	—	$580,546	$169,750	—	$1,140,296
Chief Commercial	Officer	$66,932	—	—	$674,797	$24,346	—	$766,075

Executive changes

Person	Role	Change	Effective	Filed
Chris Peetz	Board of Directors	Appointed	—	2026-08-05
Christopher Peetz	Class III director	Appointed	2026-07-15	2026-07-16
Amit D. Munshi	chair of the Compensation Committee of the Board	Appointed	2025-12-04	2025-12-08
Amit D. Munshi	new Class II director	Appointed	2025-12-04	2025-12-08
Bhaskar Chaudhuri	chair of the Compensation Committee of the Board	Retired	2025-12-03	2025-12-08
Bhaskar Chaudhuri	member of the Board of Directors	Retired	2025-12-03	2025-12-08
Latha Vairavan	Chief Financial Officer (CFO)	Appointed	—	2025-04-10
David Topper	Chief Financial Officer	Retired	2025-05-15	2025-04-10
David Topper	principal accounting officer	Appointed	2024-04-10	2024-04-10
David Topper	Chief Financial Officer	Appointed	2024-04-10	2024-04-10
L. Todd Edwards	Chief Commercial Officer	Appointed	2023-09-27	2023-09-27
John Smither	interim chief financial officer	Appointed	2023-08-31	2023-08-18
Scott Burrows	chief financial officer	Resigned	2023-08-31	2023-08-18
Ayisha Jeter	interim chief commercial officer	Appointed	—	2023-05-24
Kenneth Lock	Senior Vice President and Chief Commercial Officer	Resigned	2023-06-02	2023-05-24
Neha Krishnamohan	Class III director and member of the Audit Committee	Appointed	2022-09-02	2022-09-06

Key facts CIK 1787306 CUSIP 03969K108 13F (30d) 8 filings 7 filers Visit website Investor relations